Skeletal responses to romosozumab after 12 months of denosumab - McClung - 2021 - JBMR Plus - Wiley Online Library
Hormones.gr
Romosozumab in Postmenopausal Women with Low Bone Mineral Density | NEJM
Antiresorptive and anabolic medications used in the perioperative period of patients with osteoporosis undergoing spine surgery: their impact on the biology of fusion and systematic review of the literature in: Neurosurgical Focus
![스클레로스틴, Sclerostin [in Wnt signaling pathway]](https://blog.kakaocdn.net/dn/bFZkqH/btqF0ZBrEAV/NPBqsEaDvloAkMlq1rvhe1/img.png "스클레로스틴, Sclerostin [in Wnt signaling pathway]")
스클레로스틴, Sclerostin [in Wnt signaling pathway]
Romosozumab in the treatment of osteoporosis | Immunotherapy
Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis | Nature Reviews Endocrinology
Frontiers | Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy | Immunology
Frontiers | The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research | Immunology
Profile of romosozumab and its potential in the management of osteopor | DDDT
Romosozumab in the treatment of osteoporosis | Immunotherapy
![PDF] Profile of romosozumab and its potential in the management of osteoporosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c5f19cae86699ba8d489f33a95e2079f97e586d3/4-Figure2-1.png "PDF] Profile of romosozumab and its potential in the management of osteoporosis | Semantic Scholar")
PDF] Profile of romosozumab and its potential in the management of osteoporosis | Semantic Scholar
JCM | Free Full-Text | Osteoporosis Treatment with Anti-Sclerostin Antibodies—Mechanisms of Action and Clinical Application | HTML
Mechanism of action of romosozumab. Notes: Romosozumab is a human... | Download Scientific Diagram
Molecular understanding of pharmacological treatment of osteoporosis in: EFORT Open Reviews Volume 4 Issue 4 (2019)
EVENITY® (romosozumab-aqqg) Mechanism of Action
Mechanism of action of romosozumab. Notes: Romosozumab is a human... | Download Scientific Diagram
References in Osteoporosis treatment: recent developments and ongoing challenges - The Lancet Diabetes & Endocrinology
The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis. - Abstract - Europe PMC
![PDF] Profile of romosozumab and its potential in the management of osteoporosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c5f19cae86699ba8d489f33a95e2079f97e586d3/2-Figure1-1.png "PDF] Profile of romosozumab and its potential in the management of osteoporosis | Semantic Scholar")
PDF] Profile of romosozumab and its potential in the management of osteoporosis | Semantic Scholar
Drug discovery of sclerostin inhibitors - ScienceDirect
